A comparative study between full-dose and half-dose intravesical immune bacille Calmette –Guérin injection in the management of superficial bladder cancer
Conclusion The half dose of intravesical BCG instillation can reduce the toxicity and side-effects that are associated with the treatment of superficial bladder cancer, without affecting the efficacy of therapy.
Source: Arab Journal of Urology - Category: Urology & Nephrology Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Middle East Health | Study | Toxicology | Urology & Nephrology